SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

CLIK is trending due to a reported surge in revenue and a small float, sparking excitement about a potential massive run. The community is focused on the stock's low float and are watching for news catalysts, drawing comparisons to other stocks with similar setups. Some traders are also pointing to the stock's chart patterns as a reason for optimism.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is trending due to discussions surrounding Amazon's competitive moves in the DSP space, sparking debates about market share and potential impacts. The community is analyzing Amazon's recent offer of head-to-head testing and ADWEEK's reporting of it. Investors are closely watching Trade Desk's response and its long-term strategies in a competitive landscape.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

NEGG is trending as traders discuss a potential short squeeze, noting high borrowing costs and a seemingly limited float. Community members are debating the impact of insider activity and monitoring short interest data. Some investors suggest a buy-and-hold strategy, while others point to technical indicators.

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.

Picard Medical Inc.

Picard Medical (PMI) is trending amid significant stock volatility, prompting the company to release a statement clarifying they are unaware of any undisclosed material changes. The community is actively discussing potential dilution, short covering, and speculating about a possible pump and dump, while some remain bullish, citing the company's unique position in the artificial heart market.

Meet DragonWifBeard: The world's first AI-powered pet dragon!  More Than Just Scales: DragonWifBeard is a real-life bearded dragon revolutionizing the pet experience. He's not just any reptile – he's equipped with cutting-edge Eliza AI agent, giving him a unique personality and the ability to interact with his environment in unprecedented ways. The Future of Companionship: This groundbreaking project merges the love for pets with the limitless possibilities of AI. Witness the dawn of a new era in companionship with DragonWithBeard.

DragonWifBeard

DragonWifBeard ($DWB) is trending as the community emphasizes its potential for profit, particularly its availability on Phantom Wallet. The conversation highlights a blend of 'ancient' and 'modern' gains, with users frequently mentioning fire and wisdom as key themes. The coin's association with other Solana tokens is also part of the discussion.

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Neuphoria Therapeutics Inc.

NEUP is trending due to a significant surge, potentially driven by insider buying and a milestone payment from Merck related to their Alzheimer's program. The community is focused on the stock's low float and the potential for a short squeeze, with some expecting a continued upward trend. However, some traders are also discussing the possibility of dilution impacting future price action.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Teva- Pharmaceutical Industries Ltd. - ADR

Teva is trending as community members discuss its potential and setbacks, with some pointing to a recent FDA approval for Uzedy as a positive catalyst. Despite some positive news, negative sentiment persists regarding the stock's performance and leadership. Analysts are weighing in, with price target adjustments and discussions around the company's "Pivot to Growth" strategy.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending due to an FDA investigation into increased reports of allergic reactions to specific lots of intravenous immunoglobulin (IGIV) products, including two ADMA lots, leading to a voluntary recall. While some community members view this as a buying opportunity, citing the company's strong fundamentals and potential for a pre-earnings run-up, others are concerned about potential impacts on future earnings and are closely watching for management's response and share buyback activity. The community is also discussing the broader context of hypersensitivity reactions to IGIV drugs and ADMA's growth potential within the plasma-derived therapies market.

Clanker is an autonomous agent for deploying tokens. Currently, users may request clanker to deploy an ERC-20 token on Base by tagging it @clanker on Farcaster.

tokenbot

Clanker Crypto is trending as the community discusses its potential for significant gains due to its limited supply and recent price movements. Some users point to technical analysis, highlighting breakout patterns, while others speculate about a possible Coinbase listing and its impact on the token's value. The conversation also mentions the broader ecosystem and related tokens.

GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic disease. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

GeneDx Holdings Corp - Ordinary Shares - Class A

GeneDx Holdings Corp

GeneDx is trending following positive analyst ratings and price target increases, with community members discussing potential breakout patterns and long-term growth prospects. The company's strategic focus on genomic testing in pediatrics and recent FDA breakthrough device designation are also fueling investor interest. Some investors are closely watching upcoming earnings releases and potential for further upward momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gentherm (THRM) Surpasses Q3 Earnings and Revenue Estimates

Gentherm (THRM) delivered earnings and revenue surprises of +14.06% and +3.16%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Should Value Investors Buy Gentherm (THRM) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

MOD vs. THRM: Which Thermal Management Stock is the Better Buy?

Modine's acquisitions, growth outlook, and strong ROE stack up against Gentherm's new awards and China push in the thermal management race.


Are Investors Undervaluing Gentherm (THRM) Right Now?

Is Gentherm (THRM) Stock Undervalued Right Now?

Here Is Why Bargain Hunters Would Love Fast-paced Mover Gentherm (THRM)

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Gentherm (THRM) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Wall Street Analysts Predict a 26.72% Upside in Gentherm (THRM): Here's  What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in Gentherm (THRM). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Gentherm (THRM) Q2 Earnings Lag Estimates

Gentherm (THRM) delivered earnings and revenue surprises of -8.47% and +2.78%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Are Investors Undervaluing Gentex (GNTX) Right Now?

Gentherm, Inc. engages in the design, development, manufacturing, and marketing of heating, cooling, and ventilating devices. It operates through the Automotive and Medical segments. The Automotive segment offers automotive climate and comfort systems, cable technology, battery performance solutions, valve systems, and electronic and software solutions. The Medical segment is involved in the patient temperature management business. The company was founded by Lon E. Bell in 1991 and is headquartered in Novi, MI.

Gentherm Inc - Ordinary Shares - Class A

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

THRM
Gentherm Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest THRM News

THRMGentherm Inc - Ordinary Shares - Class A